Efficacy of Cyclic Lipopeptides Obtained from to Inhibit the Growth of Isolated from Cats

Overview

Journal Heliyon

Specialty Social Sciences

Date 2021 Sep 29

PMID 34585007

Citations 1

Authors

Paiboon Tunsagool

Sekkarin Ploypetch

Janthima Jaresitthikunchai

Sittiruk Roytrakul

Kiattawee Choowongkomon

Jatuporn Rattanasrisomporn

Affiliations

Soon will be listed here.

Abstract

Background And Aim: () is a dermatophyte fungal pathogen that causes ringworms. Cats are considered to be a dominant reservoir host enabling transmission to humans. The concerns of dermatophyte resistance were raised among the usage of antifungal drugs to treat the ringworm. This study aimed to evaluate the fungal activity of cyclic lipopeptides (CLPs) obtained from () as an alternative method for the inhibition of growth.

Materials And Methods: The culture plate of from confirmed cats with ringworm infection was provided. The purification of CLP extract, fengycin, iturin A, and surfactin was carried out from by preparative thin-layer chromatography (PTLC) coupled with solid-phase extraction (SPE) methods. Half-maximal effective concentration (EC) and agar well diffusion assays were performed to determine the efficacy of CLP extract, fengycin, iturin A, and surfactin to inhibit the growth of isolated from cats.

Results: All purified substances displayed antifungal activity to control the growth of when compared with 80% ethanol (control). EC values for CLP extract, fengycin, iturin A, and surfactin were 0.23, 0.05, 0.17, and 0.08 mg/mL, respectively. In agar well diffusion assay, the ability of CLP extract, fengycin, iturin A, and surfactin on fungal inhibition had no statistically significant difference at 24 and 48 h after treatment (p < 0.05). However, CLP extract showed a statistically significant difference on inhibition at 62.21% followed by surfactin with 59.04% at 72 h after treatment.

Conclusion: , CLPs revealed an inhibitory effect on growth which is a zoonotic pathogen that causes ringworms. This study suggests an alternative approach to control the growth of using substances obtained from as a biomedicine agent with antifungal activity.

Citing Articles

Nematicidal lipopeptides from Bacillus paralicheniformis and Bacillus subtilis: A comparative study.

Chavarria-Quicano E, De la Torre-Gonzalez F, Gonzalez-Riojas M, Rodriguez-Gonzalez J, Asaff-Torres A Appl Microbiol Biotechnol. 2023; 107(5-6):1537-1549.

PMID: 36719435 DOI: 10.1007/s00253-023-12391-w.

References

da Cunha M, Capote-Bonato F, Capoci I, Bonato D, Ghizzi L, Paiva-Lima P . Epidemiological investigation and molecular typing of dermatophytosis caused by Microsporum canis in dogs and cats. Prev Vet Med. 2019; 167:39-45. DOI: 10.1016/j.prevetmed.2019.03.019. View

Santos V, Silveira E, Pereira B . Toxicity and applications of surfactin for health and environmental biotechnology. J Toxicol Environ Health B Crit Rev. 2019; 21(6-8):382-399. DOI: 10.1080/10937404.2018.1564712. View

Waewthongrak W, Leelasuphakul W, McCollum G . Cyclic LIPopeptides from Bacillus subtilis ABS-S14 elicit defense-related gene expression in citrus fruit. PLoS One. 2014; 9(10):e109386. PMC: 4198104. DOI: 10.1371/journal.pone.0109386. View

Hu F, Liu Y, Li S . Rational strain improvement for surfactin production: enhancing the yield and generating novel structures. Microb Cell Fact. 2019; 18(1):42. PMC: 6394072. DOI: 10.1186/s12934-019-1089-x. View

Buda De Cesare G, Cristy S, Garsin D, Lorenz M . Antimicrobial Peptides: a New Frontier in Antifungal Therapy. mBio. 2020; 11(6). PMC: 7642678. DOI: 10.1128/mBio.02123-20. View

Huber W, Koella J . A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop. 1993; 55(4):257-61. DOI: 10.1016/0001-706x(93)90083-n. View

Aluffi M, Carranza C, Benito N, Magnoli K, Magnoli C, Barberis C . Isolation of culturable mycota from Argentinean soils exposed or not-exposed to pesticides and determination of glyphosate tolerance of fungal species in media supplied with the herbicide. Rev Argent Microbiol. 2020; 52(3):221-230. DOI: 10.1016/j.ram.2019.11.003. View

Alexander B, Browse D, Reading S, Benjamin I . A simple and accurate mathematical method for calculation of the EC50. J Pharmacol Toxicol Methods. 1999; 41(2-3):55-8. DOI: 10.1016/s1056-8719(98)00038-0. View

Tunsagool P, Leelasuphakul W, Jaresitthikunchai J, Phaonakrop N, Roytrakul S, Jutidamrongphan W . Targeted transcriptional and proteomic studies explicate specific roles of Bacillus subtilis iturin A, fengycin, and surfactin on elicitation of defensive systems in mandarin fruit during stress. PLoS One. 2019; 14(5):e0217202. PMC: 6532888. DOI: 10.1371/journal.pone.0217202. View

10.

Desmyttere H, Deweer C, Muchembled J, Sahmer K, Jacquin J, Coutte F . Antifungal Activities of Lipopeptides to Two Strains Possessing Different Tebuconazole Sensitivity. Front Microbiol. 2019; 10:2327. PMC: 6817503. DOI: 10.3389/fmicb.2019.02327. View

11.

Sur S, Romo T, Grossfield A . Selectivity and Mechanism of Fengycin, an Antimicrobial Lipopeptide, from Molecular Dynamics. J Phys Chem B. 2018; 122(8):2219-2226. PMC: 5832627. DOI: 10.1021/acs.jpcb.7b11889. View

12.

Martinez-Rossi N, Bitencourt T, Peres N, Lang E, Gomes E, Quaresemin N . Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus. Front Microbiol. 2018; 9:1108. PMC: 5986900. DOI: 10.3389/fmicb.2018.01108. View

13.

Moore M, WOOLDRIDGE W . Antifungal properties of various extracts of Bacillus subtilis (Tracy strain) obtained in the bacitracin recovery process. J Invest Dermatol. 1950; 14(4):265-81. DOI: 10.1038/jid.1950.34. View

14.

Lin N, Wang C, Ding J, Su L, Xu L, Zhang B . Efficacy of nanoparticle encapsulation on suppressing oxidation and enhancing antifungal activity of cyclic lipopeptides produced by Bacillus subtilis. Colloids Surf B Biointerfaces. 2020; 193:111143. DOI: 10.1016/j.colsurfb.2020.111143. View

15.

Jiang C, Li Z, Shi Y, Guo D, Pang B, Chen X . Bacillus subtilis inhibits Aspergillus carbonarius by producing iturin A, which disturbs the transport, energy metabolism, and osmotic pressure of fungal cells as revealed by transcriptomics analysis. Int J Food Microbiol. 2020; 330:108783. DOI: 10.1016/j.ijfoodmicro.2020.108783. View

16.

Horn J, Cravens A, Grossfield A . Interactions between fengycin and model bilayers quantified by coarse-grained molecular dynamics. Biophys J. 2013; 105(7):1612-23. PMC: 3822635. DOI: 10.1016/j.bpj.2013.08.034. View

17.

Gimenez D, Phelan A, Murphy C, Cobb S . Fengycin A Analogues with Enhanced Chemical Stability and Antifungal Properties. Org Lett. 2021; 23(12):4672-4676. PMC: 8289291. DOI: 10.1021/acs.orglett.1c01387. View

18.

Sidorova T, Asaturova A, Homyak A, Zhevnova N, Shternshis M, Tomashevich N . Optimization of laboratory cultivation conditions for the synthesis of antifungal metabolites by bacillus subtilis strains. Saudi J Biol Sci. 2020; 27(7):1879-1885. PMC: 7296493. DOI: 10.1016/j.sjbs.2020.05.002. View

19.

Kang B, Park J, Jung W . Antifungal evaluation of fengycin isoforms isolated from Bacillus amyloliquefaciens PPL against Fusarium oxysporum f. sp. lycopersici. Microb Pathog. 2020; 149:104509. DOI: 10.1016/j.micpath.2020.104509. View

20.

Olila D, Olwa-Odyek , Opuda-Asibo J . Antibacterial and antifungal activities of extracts of Zanthoxylum chalybeum and Warburgia ugandensis, Ugandan medicinal plants. Afr Health Sci. 2003; 1(2):66-72. PMC: 2141554. View